The DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
Role of Chemokines in Endocrine Autoimmune Diseases
Abstract
Chemokines are a group of peptides of low molecular weight that induce the chemotaxis of different leukocyte subtypes. The major function of chemokines is the recruitment of leukocytes to inflammation sites, but they also play a role in tumoral growth, angiogenesis, and organ sclerosis. In the last few years, experimental evidence accumulated supporting the concept that interferon-γ (IFN-γ) inducible chemokines (CXCL9, CXCL10, and CXCL11) and their receptor, CXCR3, play an important role in the initial stage of autoimmune disorders involving endocrine glands. The fact that, after IFN-γ stimulation, endocrine epithelial cells secrete CXCL10, which in turn recruits type 1 T helper lymphocytes expressing CXCR3 and secreting IFN-γ, thus perpetuating autoimmune inflammation, strongly supports the concept that chemokines play an important role in endocrine autoimmunity. This article reviews the recent literature including basic science, animal models, and clinical studies, regarding the role of these chemokines in autoimmune endocrine diseases. The potential clinical applications of assaying the serum levels of CXCL10 and the value of such measurements are reviewed. Clinical studies addressing the issue of a role for serum CXCL10 measurement in Graves’ disease, Graves’ ophthalmopathy, chronic autoimmune thyroiditis, type 1 diabetes mellitus, and Addison’s disease have been considered. The principal aim was to propose that chemokines, and in particular CXCL10, should no longer be considered as belonging exclusively to basic science, but rather should be used for providing new insights in the clinical management of patients with endocrine autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–213 of 213
Experimental Autoimmune Adrenalitis: A Murine Model for Addison's Disease
Fujii, Y., Kato, N., Kito, J., Asai, J., & Yokochi, T. (1992) · Autoimmunity · doi:10.3109/08916939209146129 · Cited by 34
Mariotti, S., Prete, G., Mastromauro, C., Carli, M., Romagnani, S., Ricci, M., & Pinchera, A. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211053 · Cited by 34
Self-citationAdrenal Autoimmunity: Results and Developments
Peterson, P., Uibo, R., & Krohn, K. J. E. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00283-6 · Cited by 33
Chemokine production by peripheral blood mononuclear cells in elderly subjects
Pulsatelli, L., Melicòni, R., Mazzetti, I., Dolzani, P., Meneghetti, A., Neri, S., Silvestri, T., Ravaglia, G., Forti, P., Facchini, A., et al. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00200-1 · Cited by 26
Weetman, A. P., Ajjan, R., & Watson, P. F. (1997) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(97)80708-2 · Cited by 26
Wardle, C. A., Weetman, A. P., Mitchell, R. M., Peers, N., & Robertson, W. R. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.3.8396577 · Cited by 26
Serum monocyte chemoattractant protein-1 is increased in chronic autoimmune thyroiditis
Kokkotou, E. G., Marafelia, P., Mantzos, E., & Tritos, N. A. (2002) · Metabolism · doi:10.1053/meta.2002.34717 · Cited by 24
Early chemokine expression induced by interferon-gamma in a murine model of Hashimoto's thyroiditis
Kimura, H. J., Kimura, M., Rose, N. R., & Caturegli, P. (2004) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2004.08.004 · Cited by 24
Age-Dependent Changes in CXC Chemokine Ligand 10 Serum Levels in Euthyroid Subjects
Antonelli, A., Rotondi, M., Fallahi, P., Romagnani, P., Ferrari, S. M., Ferrannini, E., & Serio, M. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.547 · Cited by 23
Self-citationAust, G., Sittig, D. F., STEINERT, M., Lamesch, P., & Lohmann, T. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01778.x · Cited by 22
15-Deoxy-Δ12,14-prostaglandin J2facilitates thyroglobulin production by cultured human thyrocytes
Kasai, K., Banba, N., Hishinuma, A., Matsumura, M., Kakishita, H., Matsumura, M., Motohashi, S., Sato, N., & Hattori, Y. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.6.c1859 · Cited by 20
Rotondi, M., Romagnani, P., Brozzetti, A., Santeusanio, F., Serio, M., & Falorni, A. (2003) · Diabetologia · doi:10.1007/s00125-003-1134-4 · Cited by 17
Self-citationHoerr, I. (2000) · doi:10.1002/1521-4141(200001)30:1
Cited by
Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.003 · Cited by 1,288
Self-citationCXCL10 and autoimmune diseases
Lee, E. Y., Lee, Z.-H., & Song, Y. W. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.12.002 · Cited by 357
CXCR3, Inflammation, and Autoimmune Diseases
Lacotte, S., Brun, S., Muller, S., & Dumortier, H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04813.x · Cited by 339
Alopecia areata: A multifactorial autoimmune condition
Simakou, T., Butcher, J. P., Reid, S., & Henriquez, F. L. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.12.001 · Cited by 309
Chemotaxis, chemokine receptors and human disease
Jin, T., Xu, X., & Hereld, D. (2008) · Cytokine · doi:10.1016/j.cyto.2008.06.017 · Cited by 283
Metadata
- Authors
- Rotondi, M., Chiovato, L., Romagnani, S., Serio, M., & Romagnani, P.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2007-08-01
- Volume
- 28
- Issue
- 5
- Pages
- 492-520
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2111700007
- Cited by
- 257
- References
- 213
- FWCI
- 7.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.